NO20012059L - Nye G-protein-koplede reseptorproteiner, DNA derav og ligander til det samme - Google Patents
Nye G-protein-koplede reseptorproteiner, DNA derav og ligander til det sammeInfo
- Publication number
- NO20012059L NO20012059L NO20012059A NO20012059A NO20012059L NO 20012059 L NO20012059 L NO 20012059L NO 20012059 A NO20012059 A NO 20012059A NO 20012059 A NO20012059 A NO 20012059A NO 20012059 L NO20012059 L NO 20012059L
- Authority
- NO
- Norway
- Prior art keywords
- present
- protein
- coupled receptor
- ligand
- protein coupled
- Prior art date
Links
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 title abstract 10
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 title abstract 10
- 239000003446 ligand Substances 0.000 title abstract 10
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 150000003839 salts Chemical class 0.000 abstract 5
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000000556 agonist Substances 0.000 abstract 3
- 102000005962 receptors Human genes 0.000 abstract 3
- 108020003175 receptors Proteins 0.000 abstract 3
- 238000012216 screening Methods 0.000 abstract 3
- 239000005557 antagonist Substances 0.000 abstract 2
- 210000004556 brain Anatomy 0.000 abstract 2
- 210000001638 cerebellum Anatomy 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 238000011002 quantification Methods 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000004064 dysfunction Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000006386 neutralization reaction Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30594998 | 1998-10-27 | ||
| JP2771099 | 1999-02-04 | ||
| JP5720799 | 1999-03-04 | ||
| JP27622599A JP4486187B2 (ja) | 1998-10-27 | 1999-09-29 | 新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド |
| PCT/JP1999/005905 WO2000024890A1 (en) | 1998-10-27 | 1999-10-26 | Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20012059D0 NO20012059D0 (no) | 2001-04-26 |
| NO20012059L true NO20012059L (no) | 2001-06-26 |
Family
ID=27458743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012059A NO20012059L (no) | 1998-10-27 | 2001-04-26 | Nye G-protein-koplede reseptorproteiner, DNA derav og ligander til det samme |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6699965B1 (https=) |
| EP (1) | EP1126028B1 (https=) |
| JP (1) | JP4486187B2 (https=) |
| KR (1) | KR20010085974A (https=) |
| CN (1) | CN1324405A (https=) |
| AT (1) | ATE394485T1 (https=) |
| AU (1) | AU6230699A (https=) |
| BR (1) | BR9914835A (https=) |
| CA (1) | CA2347294A1 (https=) |
| CZ (1) | CZ20011358A3 (https=) |
| DE (1) | DE69938666D1 (https=) |
| HU (1) | HUP0104937A2 (https=) |
| ID (1) | ID28288A (https=) |
| IL (1) | IL142428A0 (https=) |
| NO (1) | NO20012059L (https=) |
| NZ (1) | NZ510977A (https=) |
| PL (1) | PL347553A1 (https=) |
| SK (1) | SK5502001A3 (https=) |
| WO (1) | WO2000024890A1 (https=) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002536989A (ja) * | 1999-02-24 | 2002-11-05 | メルク エンド カムパニー インコーポレーテッド | ガラニン受容体と類似したｇタンパク質共役受容体 |
| US20050240008A1 (en) * | 2000-03-30 | 2005-10-27 | Tetsuya Ohtaki | Novel protein, dna thereof and process for producing the same |
| EP1168259A3 (en) | 2000-06-28 | 2003-12-17 | Hitachi, Ltd. | Data management method and system for IC card |
| JP4762481B2 (ja) | 2000-08-30 | 2011-08-31 | 株式会社セルフリーサイエンス | 無細胞タンパク質合成用転写鋳型の設計および構築、並びにこれを用いる希釈バッチ方式コムギ胚芽無細胞タンパク質合成法 |
| JP2002109169A (ja) | 2000-09-29 | 2002-04-12 | Hitachi Ltd | 作業支援方法並びにシステム及び作業支援方法を記録した記録媒体 |
| CA2430934C (en) | 2000-12-01 | 2011-06-21 | Takeda Chemical Industries, Ltd. | A method of producing sustained-release preparations of a bioactive substance using high-pressure gas |
| CA2431522A1 (en) * | 2000-12-18 | 2002-08-01 | Merck & Co. Inc. | Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof |
| WO2002057309A1 (fr) * | 2001-01-18 | 2002-07-25 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice couplee a la proteine g et adn de cette proteine |
| WO2002072816A1 (fr) * | 2001-02-26 | 2002-09-19 | Takeda Chemical Industries, Ltd. | Proteine de recepteur murin de type kiss-1 et adn correspondant |
| WO2002083735A1 (fr) * | 2001-04-06 | 2002-10-24 | Takeda Chemical Industries, Ltd. | Nouvelle proteine receptrice et son adn |
| AU2008202004A1 (en) * | 2001-09-18 | 2008-05-29 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| EP1487877B1 (en) * | 2001-09-18 | 2010-10-27 | Genentech, Inc. | Compositions and methods for the diagnosis of tumors |
| DE60219645T2 (de) | 2001-09-19 | 2007-08-09 | Takeda Pharmaceutical Co. Ltd. | Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft |
| US20050176091A1 (en) * | 2002-01-11 | 2005-08-11 | Takao Yamada | Process for producing kiss-1 peptide |
| EP2116551A1 (en) * | 2002-09-11 | 2009-11-11 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US20060241051A1 (en) | 2002-12-26 | 2006-10-26 | Chieko Kitada | Metastin derivatives and use thereof |
| US6800611B2 (en) * | 2003-01-06 | 2004-10-05 | Takeda Chemical Industries, Ltd. | Metastin derivatives and their use |
| WO2004080479A1 (ja) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 性腺機能改善剤 |
| JP4639052B2 (ja) * | 2003-03-12 | 2011-02-23 | 武田薬品工業株式会社 | 性腺機能改善剤 |
| EP1464652A1 (en) * | 2003-04-02 | 2004-10-06 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| WO2004096855A2 (en) * | 2003-04-28 | 2004-11-11 | Wyeth | Methods utilising g-protein coupled receptor 54 |
| WO2004101747A2 (en) * | 2003-05-07 | 2004-11-25 | The General Hospital Corporation | Identification and use of gpr54 and its ligands for reproductive disorders and contraception |
| WO2005040833A1 (en) * | 2003-10-21 | 2005-05-06 | Bayer Healthcare Ag | Regulation of human metastin recognising receptors |
| AR049938A1 (es) | 2004-06-25 | 2006-09-13 | Takeda Pharmaceutical | Derivados de metastina y utilizacion de los mismos |
| TWI386417B (zh) | 2005-12-22 | 2013-02-21 | Takeda Pharmaceutical | 轉移抑素衍生物及其用途 |
| US20090099334A1 (en) * | 2005-12-22 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| US8404643B2 (en) | 2005-12-22 | 2013-03-26 | Takeda Pharmaceutical Company Limited | Metastin derivatives and use thereof |
| ITMI20061607A1 (it) | 2006-08-09 | 2008-02-10 | Maria Vincenza Carriero | Peptidi con attivita farmacologica |
| TWI404726B (zh) | 2006-10-25 | 2013-08-11 | Takeda Pharmaceutical | 腫瘤轉移抑制素衍生物及其用途 |
| WO2009131191A1 (ja) * | 2008-04-24 | 2009-10-29 | 武田薬品工業株式会社 | メタスチン誘導体およびその用途 |
| PT2314609T (pt) | 2008-07-30 | 2017-03-06 | Takeda Pharmaceuticals Co | Derivado de metastina e sua utilização |
| EP2341942A1 (en) | 2008-09-19 | 2011-07-13 | Nektar Therapeutics | Polymer conjugates of therapeutic peptides |
| US20110171160A1 (en) * | 2008-09-19 | 2011-07-14 | Nektar Therapeutics | Polymer conjugates of kiss1 peptides |
| WO2010137022A1 (en) | 2009-05-27 | 2010-12-02 | Yeda Research And Development Co. Ltd | Gpr54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities |
| EP2873422A4 (en) | 2012-07-10 | 2015-12-30 | Takeda Pharmaceutical | PHARMACEUTICAL PREPARATION FOR INJECTION |
| TWI810193B (zh) | 2017-07-05 | 2023-08-01 | 大陸商尚華醫藥科技（江西）有限公司 | 一種Kiss1肽類化合物、其應用及含其的組合物 |
| CN109212217B (zh) * | 2018-11-07 | 2021-09-10 | 李玉民 | 基于amy1a蛋白胃癌检测试剂盒及其使用方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5436155A (en) * | 1991-12-31 | 1995-07-25 | Arch Development Corporation | Isolated DNA encoding a somatostatin receptor |
| WO1996005302A1 (en) | 1994-08-11 | 1996-02-22 | Takeda Chemical Industries, Ltd. | G protein coupled receptor protein, production, and use thereof |
| WO1997013778A1 (en) | 1995-10-11 | 1997-04-17 | The Penn State Research Foundation | A metastasis suppressor gene |
| US6010877A (en) * | 1997-01-10 | 2000-01-04 | Smithkline Beecham Corporation | cDNA clone HE8CS41 that encodes a novel 7-transmembrane receptor |
| US5851798A (en) * | 1997-01-27 | 1998-12-22 | Smithkline Beecham Corporation | Nucleic acid encoding human GPR14 receptor |
| US6420526B1 (en) * | 1997-03-07 | 2002-07-16 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| WO1998039448A2 (en) | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
| JP2002536989A (ja) | 1999-02-24 | 2002-11-05 | メルク エンド カムパニー インコーポレーテッド | ガラニン受容体と類似したｇタンパク質共役受容体 |
| US20020077469A1 (en) * | 1999-03-10 | 2002-06-20 | Borowsky Beth E. | DNA encoding orphan SNORF11 receptor |
| WO2004080479A1 (ja) * | 2003-03-12 | 2004-09-23 | Takeda Pharmaceutical Company Limited | 性腺機能改善剤 |
-
1999
- 1999-09-29 JP JP27622599A patent/JP4486187B2/ja not_active Expired - Fee Related
- 1999-10-26 PL PL99347553A patent/PL347553A1/xx not_active Application Discontinuation
- 1999-10-26 KR KR1020017005344A patent/KR20010085974A/ko not_active Withdrawn
- 1999-10-26 NZ NZ510977A patent/NZ510977A/xx unknown
- 1999-10-26 DE DE69938666T patent/DE69938666D1/de not_active Expired - Lifetime
- 1999-10-26 SK SK550-2001A patent/SK5502001A3/sk unknown
- 1999-10-26 CA CA002347294A patent/CA2347294A1/en not_active Abandoned
- 1999-10-26 IL IL14242899A patent/IL142428A0/xx unknown
- 1999-10-26 US US09/830,428 patent/US6699965B1/en not_active Expired - Fee Related
- 1999-10-26 EP EP99949421A patent/EP1126028B1/en not_active Expired - Lifetime
- 1999-10-26 WO PCT/JP1999/005905 patent/WO2000024890A1/ja not_active Ceased
- 1999-10-26 CZ CZ20011358A patent/CZ20011358A3/cs unknown
- 1999-10-26 HU HU0104937A patent/HUP0104937A2/hu unknown
- 1999-10-26 BR BR9914835-8A patent/BR9914835A/pt not_active IP Right Cessation
- 1999-10-26 AT AT99949421T patent/ATE394485T1/de not_active IP Right Cessation
- 1999-10-26 CN CN99812722A patent/CN1324405A/zh active Pending
- 1999-10-26 AU AU62306/99A patent/AU6230699A/en not_active Abandoned
- 1999-10-27 ID IDW20010936A patent/ID28288A/id unknown
-
2001
- 2001-04-26 NO NO20012059A patent/NO20012059L/no not_active Application Discontinuation
-
2004
- 2004-02-05 US US10/771,417 patent/US7314754B2/en not_active Expired - Fee Related
-
2007
- 2007-10-24 US US11/976,414 patent/US7608409B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20080131976A1 (en) | 2008-06-05 |
| JP2000312590A (ja) | 2000-11-14 |
| IL142428A0 (en) | 2002-03-10 |
| JP4486187B2 (ja) | 2010-06-23 |
| SK5502001A3 (en) | 2002-01-07 |
| BR9914835A (pt) | 2002-06-18 |
| DE69938666D1 (de) | 2008-06-19 |
| NZ510977A (en) | 2002-10-25 |
| WO2000024890A1 (en) | 2000-05-04 |
| US20040180407A1 (en) | 2004-09-16 |
| EP1126028B1 (en) | 2008-05-07 |
| CN1324405A (zh) | 2001-11-28 |
| PL347553A1 (en) | 2002-04-08 |
| CA2347294A1 (en) | 2000-05-04 |
| ATE394485T1 (de) | 2008-05-15 |
| US6699965B1 (en) | 2004-03-02 |
| KR20010085974A (ko) | 2001-09-07 |
| AU6230699A (en) | 2000-05-15 |
| EP1126028A4 (en) | 2002-11-27 |
| US7608409B2 (en) | 2009-10-27 |
| ID28288A (id) | 2001-05-10 |
| US7314754B2 (en) | 2008-01-01 |
| CZ20011358A3 (cs) | 2001-08-15 |
| EP1126028A1 (en) | 2001-08-22 |
| HUP0104937A2 (hu) | 2002-04-29 |
| NO20012059D0 (no) | 2001-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012059L (no) | Nye G-protein-koplede reseptorproteiner, DNA derav og ligander til det samme | |
| DK0530265T3 (da) | DNA kodende for humane 5-HT1D-receptorer og anvendelser deraf | |
| PT868519E (pt) | Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2 | |
| NO2010021I2 (no) | Denosumab | |
| DK1650219T3 (da) | Humane TOLL-homologer | |
| DE69831083D1 (de) | Reprimiertes trans-aktivatorsystem zur charakterisierung von protein-protein interaktionen | |
| ATE189607T1 (de) | Dna codierend für einen menschlichen neuropeptid y/peptid yy/pankreaspolypeptid-rezeptor (y4) und seine verwendung | |
| DE69938183D1 (de) | Verwendungen eines borreliaziden epitops des aussermembranproteins c von borrelia burgdorferi (ospc) als impstoff | |
| DE69233496D1 (de) | Dna kodierend für den menschlichen 5-ht 1e-rezeptor und seine verwendungen | |
| Trujillo et al. | Analysis of major ovine milk proteins by reversed-phase high-performance liquid chromatography and flow injection analysis with electrospray ionization mass spectrometry | |
| EP1560025A3 (en) | Specific markers for diabetes | |
| EP0960937A4 (en) | NEW SEMAPHORIN GENE: SEMAPHORIN Y | |
| ATE284955T1 (de) | Map-kinase: polypeptide, polynukleotide und ihre verwendung | |
| ATE284034T1 (de) | Verfahren zum nachweis von protein s | |
| ATE294816T1 (de) | Neue, physiologisch aktive peptide und ihre verwendung. | |
| EP1403281A4 (en) | NEW LIGAND AND DNA FROM IT | |
| EP1584925A4 (en) | NEW SCREENING PROCEDURE | |
| WO2003019197A3 (en) | Diabetic model | |
| WO2001085989A3 (de) | Hyphenspezifische faktoren aus candida albicans | |
| DE602004023493D1 (de) | Neues screening-verfahren | |
| Perry et al. | Pharmacology of Hypocretin/Orexin Peptides and Small Molecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |